Yujiro S. Hata - 18 Feb 2025 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
President and CEO, Director
Signature
/s/ Andres Ruiz Briseno, as Attorney-in-Fact for Yujiro Hata
Issuer symbol
IDYA
Transactions as of
18 Feb 2025
Net transactions value
+$250,012
Form type
4
Filing time
19 Feb 2025, 06:00:15 UTC
Previous filing
16 May 2024
Next filing
28 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDYA Common Stock Options Exercise $250,012 +12,808 +1.9% $19.52 690,695 18 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Options Exercise $0 -12,808 -6.6% $0.000000 182,192 18 Feb 2025 Common Stock 12,808 $19.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option are fully vested and exercisable.